← SynDRA
Z160
SynDRA canonical compound SYN0020704 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | CACNA1B |
| Mechanism of action | N-type calcium channel blocker |
All known targets
Mechanisms of action (all sources)
- N-type calcium channel blocker
- CACNA1B BLOCKER
- Voltage-gated N-type calcium channel alpha-1B subunit blocker
- CACNA2D1 INHIBITOR
Drug classes
Cross-references
Synonyms
- Z-160
- MK-6721
- MK6721
- NMED-160
- NP-118809
- NP118809
- 1-[4-(Diphenylmethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone
- UNII-TX3R141LEP
- TX3R141LEP
- CHEMBL604710
- Piperazine, 1-(diphenylmethyl)-4-(1-oxo-3,3-diphenylpropyl)-
- 1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenylpropan-1-one
- AC1NLRM8
- GTPL7765
- SCHEMBL4180792
- CTK1D3910
- DTXSID70407284
- VCPMZDWBEWTGNW-UHFFFAOYSA-N
- MolPort-001-545-055
- EX-A2422
- BCP08259
- KS-00000T6R
- ZINC20509316
- 3934AH
- STK411255
- AKOS003297641
- DB12743
- MCULE-3294187169
- CS-1361
- API0014038
- ACM41332245
- NP 118809
- 1-(4-Benzhydryl-piperazin-1-yl)-3,3-diphenylpropan-1-one
- RefChem:934473
- DTXCID20358136
- MFCD03387795
- orb1299910
- 1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenyl-propan-1-one
- GLXC-10428
Look up Z160 in the interactive SynDRA portal →